Reviewed by Peptide Treatments Medical Advisory Board
PE-22-28: Side Effects & Safety
Known side effects, safety considerations, and adverse reaction data for PE-22-28.
Back to PE-22-28 overviewData source: Side effect data comes from preclinical research and anecdotal reports. This compound has not undergone formal human clinical trials.
Reported Side Effects (5 items)
| # | Side Effect |
|---|---|
| 1 | No human safety data — zero human studies conducted |
| 2 | Theoretical CNS effects from potassium channel modulation |
| 3 | Theoretical seizure risk from channel modulation in brain |
| 4 | Theoretical cardiac effects — TREK channels are expressed in cardiac tissue |
| 5 | No established adverse event profile |